Medexus Pharma, Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of a Recombinant Factor IX Product, APVO101, in Previously-Treated Pediatric Patients With Hemophilia B (NCT03855280) | Medexus Pharma, Inc. | 2020-01-16 |
Track Medexus Pharma, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.